Double maintains 4 strategies that include RARE - Ultragenyx Pharmaceutical, Inc.
Finnhub
Presenter SpeechSalveen Richter Great. Good morning, everyone. Thank you so much for joining us. I'm Salveen Richter, biotechnology analyst at Goldman Sachs, and we're really pleased to have the...
Yahoo
NOVATO, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases, today announced that Emil Kakkis, M.D., Ph.D., the company's chief executive officer, will participate in a fireside at the Goldman Sachs 46th Annual Global Healthcare Conference on Tuesday, June 10, 2025, at 10:00 a.m. ET. The live and archived webcast of
Yahoo
As the U.S. market navigates a complex landscape with the S&P 500 experiencing slight declines and Treasury yields on the rise, investors are closely monitoring legislative developments that could impact fiscal policy and economic growth. In this environment, high-growth tech stocks remain a focal point for those seeking potential opportunities in innovation-driven sectors, where adaptability and strong fundamentals can be key indicators of resilience amidst broader market fluctuations.
Yahoo
NOVATO, Calif., May 20, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44,805 restricted stock units of the company’s common stock to 20 newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Emplo
Yahoo
NOVATO, Calif., May 14, 2025 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) released its 2024 Impact Report today, which covers the company’s approach to corporate responsibility. The report highlights efforts to transform the lives of individuals and families affected by rare diseases, empower its employees, and make a meaningful impact on the communities it operates within and serves. “Since founding Ultragenyx 15 years ago, I’ve sought to build a next-generation rare diseas
Yahoo
Ultragenyx Pharmaceutical Inc. ( NASDAQ:RARE ) shareholders are probably feeling a little disappointed, since its...
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
FMTO | -11.42% | $4.90K | -99.92% | 0.00% |
LITB | -8.12% | $23.54M | -75.48% | 0.00% |
BTCT | -7.41% | $19.24M | +37.16% | 0.00% |
AIFU | -7.28% | $3.21B | -4.38% | 0.00% |
AQB | -6.22% | $3.14M | -53.66% | 0.00% |
CCEC | -6.10% | $1.02B | +3.91% | 2.86% |
KR | -5.89% | $43.65B | +30.13% | 1.95% |
PRA | -5.29% | $1.17B | +83.65% | 0.00% |
FARO | -5.14% | $816.92M | +152.62% | 0.00% |
NEUE | -5.02% | $61.16M | +27.09% | 0.00% |
CNR | -4.50% | $3.89B | -24.22% | 0.95% |
VHC | -4.46% | $36.37M | +130.03% | 0.00% |
GO | -4.46% | $1.34B | -34.00% | 0.00% |
VSA | -4.29% | $8.76M | -16.94% | 0.00% |
T | -4.15% | $202.84B | +59.81% | 3.95% |
K | -3.91% | $27.71B | +38.87% | 2.84% |
VZ | -3.89% | $181.34B | +8.42% | 6.31% |
HUSA | -3.78% | $24.55M | +27.24% | 0.00% |
CARV | -2.97% | $7.97M | -10.34% | 0.00% |
AWK | -2.66% | $27.58B | +9.39% | 2.19% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
COGT | 50.78% | $806.10M | -15.96% | 0.00% |
RVMD | 50.77% | $7.56B | +5.10% | 0.00% |
CRNX | 50.73% | $2.98B | -29.91% | 0.00% |
DNLI | 50.01% | $2.11B | -29.81% | 0.00% |
RNA | 48.45% | $3.78B | -20.86% | 0.00% |
SNDX | 47.57% | $881.99M | -49.03% | 0.00% |
ARWR | 47.20% | $2.17B | -39.09% | 0.00% |
DYN | 46.89% | $1.64B | -56.43% | 0.00% |
NUVL | 46.11% | $5.62B | +0.59% | 0.00% |
XNCR | 46.02% | $654.06M | -55.34% | 0.00% |
ROIV | 45.92% | $7.70B | +5.89% | 0.00% |
KYMR | 45.77% | $3.06B | +41.06% | 0.00% |
DASH | 45.67% | $92.78B | +95.41% | 0.00% |
IONS | 45.63% | $5.66B | -12.45% | 0.00% |
XENE | 45.40% | $2.51B | -12.05% | 0.00% |
OCUL | 44.86% | $1.39B | +51.83% | 0.00% |
IDYA | 44.61% | $1.94B | -41.80% | 0.00% |
BEAM | 44.48% | $1.72B | -31.40% | 0.00% |
KRYS | 44.47% | $3.96B | -22.90% | 0.00% |
RGNX | 44.23% | $464.99M | -25.30% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XBI | 65.03% | $4.76B | 0.35% |
GNOM | 62.86% | $44.57M | 0.5% |
IBB | 60.73% | $5.43B | 0.45% |
BBH | 55.77% | $341.71M | 0.35% |
PINK | 54.88% | $132.70M | 0.5% |
PBE | 54.28% | $226.09M | 0.58% |
PTH | 53.86% | $103.32M | 0.6% |
FBT | 53.68% | $1.03B | 0.54% |
XPH | 50.77% | $153.44M | 0.35% |
ARKG | 50.71% | $974.51M | 0.75% |
VHT | 49.99% | $15.62B | 0.09% |
FHLC | 49.88% | $2.48B | 0.084% |
QDVO | 47.95% | $68.33M | 0.55% |
IYH | 47.77% | $2.79B | 0.39% |
FXH | 47.18% | $911.90M | 0.62% |
IXJ | 47.04% | $3.86B | 0.41% |
XLV | 45.82% | $34.69B | 0.09% |
IHE | 45.53% | $577.23M | 0.39% |
QQQJ | 45.00% | $611.41M | 0.15% |
AOM | 44.57% | $1.51B | 0.15% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -29.66% | $104.89M | 0.59% |
BTAL | -28.54% | $291.96M | 1.43% |
VIXY | -26.99% | $181.73M | 0.85% |
TPMN | -19.21% | $30.75M | 0.65% |
USDU | -11.46% | $163.37M | 0.5% |
IVOL | -11.21% | $358.40M | 1.02% |
CTA | -9.35% | $1.09B | 0.76% |
UUP | -9.29% | $195.17M | 0.77% |
KCCA | -8.27% | $98.43M | 0.87% |
BILZ | -7.44% | $840.32M | 0.14% |
FTSD | -7.35% | $228.58M | 0.25% |
SHYM | -6.43% | $324.56M | 0.35% |
ULST | -6.17% | $667.54M | 0.2% |
USFR | -5.65% | $18.68B | 0.15% |
CLIP | -5.31% | $1.50B | 0.07% |
TFLO | -4.84% | $6.90B | 0.15% |
CANE | -4.63% | $9.94M | 0.29% |
STOT | -3.97% | $238.61M | 0.45% |
XHLF | -3.25% | $1.66B | 0.03% |
JMST | -2.59% | $3.96B | 0.18% |
Current Value
$37.221 Year Return
Current Value
$37.221 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
KRBN | 0.07% | $165.69M | 0.85% |
BIL | -0.16% | $43.88B | 0.1356% |
STPZ | 0.26% | $452.13M | 0.2% |
TDTT | 0.28% | $2.59B | 0.18% |
FXY | -0.53% | $862.15M | 0.4% |
SHYD | -0.83% | $325.69M | 0.35% |
LDUR | 1.14% | $917.46M | 0.5% |
BILS | 1.54% | $3.93B | 0.1356% |
FMF | 2.02% | $158.15M | 0.95% |
BUXX | 2.13% | $309.41M | 0.25% |
TBLL | -2.15% | $2.24B | 0.08% |
BSMW | 2.25% | $102.44M | 0.18% |
BOXX | 2.29% | $6.64B | 0.19% |
SMB | 2.50% | $273.00M | 0.07% |
JMST | -2.59% | $3.96B | 0.18% |
DBE | 2.77% | $49.77M | 0.77% |
UGA | 2.86% | $74.24M | 0.97% |
SPTS | 2.97% | $5.78B | 0.03% |
TBIL | 2.97% | $5.90B | 0.15% |
WEAT | 3.18% | $118.20M | 0.28% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LTM | -0.30% | $11.50B | -96.47% | 2.61% |
DADA | -0.32% | $514.44M | +37.85% | 0.00% |
CMTL | 0.36% | $57.32M | -8.02% | 0.00% |
BPT | -0.45% | $15.09M | -71.10% | 0.00% |
FYBR | -0.47% | $9.03B | +44.11% | 0.00% |
HE | 0.50% | $1.81B | +7.26% | 0.00% |
EXC | 0.79% | $43.66B | +21.69% | 3.61% |
TPB | -0.86% | $1.35B | +145.53% | 0.37% |
CNP | -0.87% | $23.74B | +17.89% | 2.32% |
TEF | 0.89% | $29.57B | +20.46% | 5.84% |
SRRK | 0.89% | $3.08B | +243.39% | 0.00% |
UUU | 0.93% | $7.19M | +93.17% | 0.00% |
CME | 1.01% | $97.12B | +36.71% | 3.92% |
DFDV | -1.03% | $379.06M | +2,332.08% | 0.00% |
USM | 1.05% | $5.08B | +12.20% | 0.00% |
CNX | -1.06% | $4.73B | +32.98% | 0.00% |
AVDX | 1.26% | $2.01B | -9.97% | 0.00% |
CODI | -1.31% | $451.42M | -72.86% | 16.30% |
PINC | -1.35% | $1.86B | +22.80% | 3.74% |
CALM | -1.41% | $5.14B | +64.39% | 6.97% |